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Noninvasive methodologies formeasuringcarcinogenexpoure inhumans, basedonthe useofurinary markers, are
beingdevelopedandvalidatedforuseinmolecularepidemiologicalstudies. Arangeof3-alkyladenines canbedetermined
in urinesamples byanimmunoafflnty puriflcation-GC/MS approach[3-methyladenine,3-ethyladenine,3-(2-hydroxy-
ethyl)adenine, and 3-benzyladeninel. Using this method, recent results in human subjects suggest that urinary
3-alkyladenines arepotentially usefl markersofalkylatingagentexposure, particularlywherethebackgroundsofsuch
adducts are much lowerthan3-methyladenine. Urinary excretionofS-benzylmercapturic acid has beenstudied in ex-
perimentalanimalsasamarkerofexposuretobenzylatingagentssuchasN-nitroso-methylbenzylamine. 3-Nitrotyrosine
(NTyr) is formed in vivo intissue or bloodproteinsafter exposure to nitrosating and/ornitrating agents such as tetra-
nitromethane. After turnover of proteins, NTyr is released and excreted in urine as metabolites 3-nitro-4-hydroxy-
phenylacetic aadand3-nitro-4-hydroxyphenylaceticacid, whicharedeterminedbyGCwithathermal energyanalyzer.
Thesensitivity andspecificit,combinedwitheaseofuse, ofthesenoninvasivebimonitoringapproachesmeansthatthey
may bereadilyinorporated intomolecularepidemiologicalstudiesinwhich qxpue tonitrosating andalkylating agents
may be important risk factors.
Introduction
Inthe rapidly expanding fieldofmolecularepidemiology, the
precise determination ofindividual exposure to carcinogens is
regarded as adesirablegoal. Itwould,nevertheless, be amistake
to translate this objective into one ofthe determination of in-
dividual cancerrisk [although thisremains apopular idea(1)].
In contrast, it is clear that groups of people at high risk of
developing aparticular cancer maybeidentifiedusingmolecular
markers of carcinogen exposure. A number of methods are
available to determine human exposure to carcinogens and are
based ontheideathatinitiation, via formationofmutagenic le-
sions inDNA, is acrucial (butnotsufficient) stepinmultistage
carcinogenesis (2). Thus, characteristic adducts can be deter-
mined inDNAextractedfrom avarietyofsourcesinducingtarget
tissues (obtainedduring surgery oratnecropsy), orfromnucle-
ated blood cells such as lymphocytes. This approach has une-
quivocally demonstrated human exposure to a range ofagents
arising fromfood [e.g., aflatoxin B1 (3)], occupation [e.g., ben-
zo[aJpyrene (4)], and lifestyle [e.g., tobacco smoking (5)].
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Blood protein adducts to these same exposures have been ex-
ploitedas surrogatemarkersofDNAdamage(3,5). Allofthese
methods require tissue or blood samples which may limit the
numbersofsamplesavailable foranalysis. Inaddition, levelsof
adducts in nontarget tissues may not necessarily be good in-
dicatorsoftargettissueexposureorevenofwhole-bodyburden.
It is from this standpoint that the idea of using noninvasive
methods based onurinary analysis has beendeveloped. Ofthe
many typesofDNAdamagearising fromcarcinogenexposure,
DNAalkylationhasbeenextensively studiedandbiomonitoring
methodsbasedonthisphenomenon formthemainfocusofthis
review.
As mentionedabove, measuresofhuman exposure to agents
resulting incharacteristic DNAdamageareamongthemostim-
portanttypesofinformation toobtain, and itiscrucial to show
thatanyindirectmethod(suchasurinaryanalysis)cangiverele-
vantinformation. WorktyCraddockandMagee(6) showedthat
exposureofrats, whoseDNAwaslabeledwith14C, to3H-labeled
dimethylnitrosamine (NDMA) resultedinurinaryexcretionof
doubly labeledN7-methylguanine (N7-MeGua). It was shown,
unambiguously, that most ofthis urinary adduct was derived
from liver, which is the major target organ for NDMA car-
cinogenesis. Morerecently, Gombaretal. (7)showedthatcoad-
ministrationof['4Claminopyrine andnitrite(acombinationthat
resultsinin uwv formationof['4CJNDMA)resultedinexcretionSHUKER ETEAL.
of ['4C]N7-MeGua, which correlated well with liver DNA
methylation. Moreover, excretionof['4C]N7-MeGua wasdetect-
able at doses where in situ methylation was undetectable due to
practical problems in obtaining sufficient DNA fromliver forad-
duct analysis at low levels of modification (whereas urinary
N7-MeGua was derivedfrom the wholeorgan and possibly other
sites). Bennettetal. (8) showed inrats thaturinary excretion of
aflatoxin B,-guanine adductcorrelated well with levelsofadduct
in the liver (which is the target organ). These results suggested
that determination ofexcreted DNA adducts (or alkylpurines)
that arise as a consequence of DNA repair mediated by DNA
glycosylases (9) form thebasis ofnoninvasive methods fordeter-
miningofDNAdamage following human exposuretoalkylating
carcinogens.
Inabroadercontext, itmaybeuseful toobtaininformationon
the whole-body burden ofalkylating agents and/or precursors.
Many alkylating carcinogens react with glutathione (GSH) in
vivo andgive rise tomercapturic acids(MAs), which in many
cases represent the major urinary metabolite(10). SN2 alkyl-
ating agents (suchasalkyl halides, epoxides, andalkylsulfonates)
cangive upto 50% oftheadministered dose asMAs, which has
ledtomuchinterest intheuseofMAsasurinary markers ofex-
posure to SN2 alkylating agents (11). In contrast,SN1 alkylating
agents such as alkyldiazonium ions (the presumed active
metabolites ofN-alkyl-N-nitroso compounds) tendto give much
lower yields although fewer of these compounds have been
studied in this respect [e.g., dimethylnitrosamine (12), N-
nitroso-di-n-butylamine (13), and N-nitroso-N-methylbenzyl-
amine (NMBA)].
Fromthepointofviewofhumanbiomonitoringto alkylating
carcinogens, mercapturic acids offer the possibility of nonin-
vasively measuring thebiological effective dose of alkylating
species. Thereareindications, however, thattheuse ofmercap-
turic acids must be approached with care. Many studies in
humans have made use ofmethods to determine total urinary
thioethers (which include MAs), and in many cases no dif-
ferences could be detected between controls and exposed sub-
jects with wide variation in individual levels (11). Aringer and
Lidums(14)havealsodrawnattentiontotheproblems ofdietary
confounding inthe totalurinary thioether method. As a conse-
quence, it has been recognized that the determination of in-
dividualmercapturic acids is notonlydesirable becauseofsen-
sitivity, butalso adds tothespecificity ofthe method, as in the
caseofacrylonitrile(15),benzene(16)andethylene oxide (17).
IndividualMAs canbedeterminedbyanumberofmethods in-
cludingGC(15), HPLC-electrochemical detection(18), HPLC-
fluorescence ofderivatives (17), and GC-MS (19).
Endogenous formation of N-nitroso compounds has been
showntooccur inhumans, usingN-nitrosamino acids excreted
inurineasamarker(20,21). CarcinogenicN-nitrosocompounds
appeartobeformedmainly inthestomachbythereactionofcer-
tain nitrogen-containing compounds with nitrite under acidic
conditions. However,endogenousnitrosationmayalsooccur in
otherorgans suchasthelung(22) andskin(23) after exposure
to oxides ofnitrogen and in inflamed or infected tissues by ac-
tivatedmacrophagesandbacteria(24,25), although such reac-
tionshavenotyetbeendemonstratedtooccurintissues in vivo.
We are currently developing and validating noninvasive
methodologies, basedontheuse ofurinary markers, for even-
tual use in humanbiomonitoring studies. This approach is divid-
ed into three parts: a) an assessment of DNA damage by
measurement ofexcretedalkylpurines b) the determination of
specific urinary mercapturic acids, and c) the evaluation of
precursors, e.g., endogenous nitrosation potential using 3-
nitrotyrosine metabolites. Recent results in these areas are
reviewed in this paper.
Urinary Alkylpurines
AlkylationatN-3 ofadenine isamajor route ofDNA-adduct
formation formanyalkylating carcinogens (26). The resulting
3-alkyldeoxyadenosines are unstable and rapidly depurinate
either spontaneously or via the action of specific DNA gly-
cosylases togivethecorresponding 3-alkyladenines (3-alkAde)
(9).
Wehaverecently shownthat3-methyladenine (3-MeAde) can
be rapidly quantitated in human urine by immunochemical
and/or GC-MS methods(27,28). Inarecent study ofcancer pa-
tientsreceivingmethylnitrosourea(MNU, atatotal single dose
of300or600mg) aspartofacombination chemotherapy, 24-hr
urine samples were collected from each patient immediately
before and after MNU administration. Analysis of urinary
3-MeAde showed, in every case, increased excretion of this
marker of methylation after treatment. Overall, a dose-de-
pendent excretion of3-MeAde was observed, and preliminary
experiments suggest some correlation between methyl adducts
(7-methylguanine andO6-methylguanine) in lymphocyte DNA
and urinary 3-MeAde excretion (Shuker et al., manuscript in
preparation).
Theuseof3-MeAdeasamarkerofmethylatingagentexposure
tolowlevelsofmethylatingagents iscomplicated by a relative-
ly highurinary background. However, recent studies have in-
dicatedthatsimpledietarymanipulation can virtually eliminate
thisbackground(27). In anexperimentdesigned toexamine the
effectofcigarettesmoking onurinarymethyl adduct excretion,
threehealthyvolunteers (current orex-smokers) agreed to col-
lect 24-hr urine samples for 10 consecutive days. During this
period, they consumed normal diets, and smoked if they
wished, ondays 1, 2, 9, and 10. On days 3-8 they consumed a
balancedliquiddietandbottledwater, which was shown to con-
tain avery low amountofpreformed 3-MeAde (27). On days 5
and6, thesubjects wereallowedto smoketheir normal brand of
cigaretteadlibitum. Urines wereanalyzed for 3-MeAde levels,
andtheresults are shown inFigure 1. Itisclear that the dietary
controlrapidly lowers andstabilizesurinary 3-MeAde excretion
(interestingly, aslight excess ofexcretion over intake is always
observed) andthatcigarettesmoking markedly increases levels
ofthismarker. Inviewoftheapparentubiquitous occurrence of
preformed 3-MeAde, ananalysis oftobacco smoke (from each
brandused)wasundertaken, andasmall amount was detected.
However, innocasedidthisbackground account for more than
10% oftheobserved increase. Therapidrise and fall ofurinary
3-MeAde, isconsistentwithendogenous DNAmethylation and
rapid repairby tobacco smoke constituents, such as tobacco-
specific nitrosamines (Prevost and Shuker, manuscript in
preparation).
We have nowdeveloped a method for analyzing several dif-
ferent3-alkyladenines simultaneously.Immunoaffinity gel was
prepared by coupling monoclonal antibody EM-6-47, which
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FIGURE 1. Excretion patternsof3-methyladenine (3-MeAde) inthreesmokers
oncontrolled diets. (Hatchedbars), 3-MeAdepreformed incigarettes; (solid
bars), 3-MeAde preformed in diet.
cross-reacts with a rangeof3-alkyladenines (29), toprotein A-
Sepharose CL-4B. Columns were prepared in a similar way to
that described recently (28). The full details ofthepreparation
and characterization ofthese immunoaffinity columns will be
described elsewhere (Prewvst et al., manuscript inpreparation).
Thus far, analytical procedures for 3-MeAde, 3-ethyladenine
(3-EtAde), 3-(2-hydroxyethyl)adenine (3-HOEtAde), and
3-benzyladenine (3-BzAde) have been developed. Deuterated
internal standards (d3-3-MeAde, d5-3-EtAde, d4-3-HOEtAde,
and d7-3-BzAde) were synthesized by standard methods and
were routinely added to urine samples (5 mL) before im-
munoaffinity purification. Selected ion monitoring using a low
resolution quadruple GC-MS system (Hewlett Packard 5970A)
was used to quantitate the 3-alkAde. A representative GC-MS
trace offour 3-alkyladenines with corresponding internal stan-
dards is shown in Figure 2. Using this approach a number of
studies havebeen carriedout, andthemainconclusions are sum-
marized below:
1. Background levels in humans of3-EtAde (0.5 nmole/24
hr) and 3-HOEtAde (6-10 nmole/24 hr) aremuch lower
than3-MeAde (50-100nmole/24hr), with 3-EtAdelevels
being very stable and little affected by changes in diet.
2. In two human volunteers, the metabolism of some
3-alkyladenines was studiedusingdeuteratedcompounds.
Recoveries ofd3-3-MeAde, d5-3-EtAde, d4-3-HOEtAde,
andd7-3-BzAde inthe24hrafteroraladministration were
93, 70, 93, and 23%, respectively.
3. Preliminary results with 3-EtAde suggestthatthere may
be some increase with smoking, although the source of
ethylating agent(s) is as yet unknown.
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FIGURE 2. Selected ion monitoring traces offour 3-alkyladenines and their
corresponding deuterated internal standards.
Specific Mercapturic Acids
Measures ofalkylating agent exposure based on total urinary
mercapturic acids are often confounded by the presence of
naturalbackground levels. In contrast, thedetermination ofin-
dividual mercapturic acids should be characteristic of a par-
ticular exposure.
In view of interest in the role of N-nitroso-N-methyl-
benzylamine (NMBzA) as a possible etiological agent in
esophageal cancer inChina, theutilityofS-benzylmercapturic
acid(SBzMA) as amarkerofbenzylation was investigated. The
excretionofSBzMAintheurineofratstreatedwithNMBzA was
determinedbyGC-MSusingd7-SBzMAas anintenalstandard.
The amountofurinarySBzMAvariedwiththedoseofNMBzA
(up to 5 mg/kg) and with rat strain. For the three strains in-
vestigated, most of a 2.5 mg/kg dose of SBzMA was excreted
within24hr. ComparisonofthelevelsofSBzMAexcretedby rats
treatedwithequivalentdosesofeitherNMBzA orbenzaldehyde
indicates that urinary SBzMA is derived mainly from ben-
zylating species resulting fromthehydroxylationofthe methyl
group ofNMBzA (30).
In view ofthe success ofimmunochemical methods, in par-
ticular, immunoaffinitypurification, inthe areaofurinary DNA
adducts, current work is aimed atpreparing antibodies against
mercapturic acids either individually (e.g., SBzMA) or as a
group.
Endogenous Nitrosation
3-Nitrotyrosine (NTyr) intissue orblood proteins was evalu-
ated as a possible exposure marker for exogenous and en-
dogenous nitrosating ornitrating agents. A sensitive and selec-
tive method foranalyzing NTyrby gas chromatography with a
thermal energyanalyzer(GC-TEA) wasdeveloped. Usingthis
method, kinetic studies werecarried out. It was foundthat free
and protein-bound tyrosine residues easily react with nitrat-
ing/nitrosating agents to yield NTyr. NTyr formation in vivo
showed adosedependentincrease in NTyr inbothplasma pro-
teins andhemoglobin obtained from rats24 hrafterIPinjection
ofvariousdoses (0.5-2.5 ymole/rat) oftetranitromethane. Ma-
jor urinary metabolites of NTyr, given orally to rats, were
isolated and identified byGC-MS as 3-nitro-4-hydroxyphenyl-
acetic acid (NHPA) and 3-nitro-4-hydroxyphenyllactic acid
(NHPL). About 44 and 5% of the oral dose of NTyr (100
lsg/rat) wasexcreted as NHPAandNHPL, respectively. Eleven
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24-hr human urine samples were analyzed for NHPA by GC-
TEAafterethylacetateextraction andHPLC purification: quan-
tities rangingfrom0to7.9Ag/24hr(mean ± SD, 2.8 ± 2.3, n =
11) weredetected (detection limit0.2 ug/L). Thus, NTyrinpro-
teins oritsmetabolites inurinecanbereadilyanalyzedbyGC-
TEA asamarkerforendogenous nitrosation andnitration (31).
Initial attempts to prepare antibodies to NTyr in order to
prepare immunoaffinity columns were not particularly suc-
cessful, andanapproachusing novelhaptenic formsofNTyris
currently being pursued.
Discussion
Themethodsdescribedhereareundergoingcontinuousrefine-
ment, particularly in the area of specificity, as well as being
thoroughly validated. Acriticismthatmaybeleveledagainstthe
useofurinary markers suchasexcretedadducts isthattheymay
be derived from total nucleic acid alkylation (i.e., DNA and
RNA) because only the modified purine base is excreted.
Although anexperimentalapproach involving theuseofstable
isotope labeled DNA in vivo is beingdeveloped todirectly ad-
dress thisquestion (Shuker, unpublisheddata), itisnonetheless
interesting to consider the published information about RNA
alkylationandrepairandcompareittothatonDNAalkylation.
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-
methyl-N-nitrosourea (MNU) reactin vitrowithvarious forms
ofRNAtogiveprimarily7-methylguanine(7-MeGua; 80-90%)
alongwithsmall amountsofotheradducts [06-MeGua, 3-4%;
I-MeAde, 2-4%; 3-MeAde,
- 1% (32,33)]. Similarpatternsof
adductformationwereobtainedinliverribosomalRNA(which
makesup > 80% oftotalRNA)ofratstreatedwithNDMA(34).
Interestingly, there isapparently norepairofmethyladducts in
liver RNA in either rats or Syrian golden hamsters. 7-Methyl-
guanine in rat liver RNA, as a result ofmethylating agent ex-
posure, disappears with the same kinetics as labeled RNA It112
= 5 days (35)]. Adduct ratios did notalter over a4-day period
inhamster liver RNAaftertreatmentwith NDMA, suggesting
thatevenminorproductssuchas 06-MeGuaand3-MeGuawere
not repaired (36). In comparison, various adducts in rat liver
DNA after treatment with NDMA underwent active and
sometimes rapid repair (adducts t /2: 7-MeGua, 29 hr;
06-MeGua, 21 hr; 3-MeAde, 6.5hr),withsimilarresultsbeing
obtained for ethyl adducts after treatment with N-ethyl-N-
nitrosourea (37). Overall, theseresults suggestthatincreases in
urinary alkylated purinebases at shorttime periods following
alkylatingagentexposurearelikelytobemainlyofDNAorigin.
Itisclear,therefore, thatnoninvasivemethods formeasuring
DNAdamagebasedontheurinaryexcretionofrepairedadducts
is both technologically feasible, based on recent advances in
analytical methodology, and scientifically valid, based on the
published literature. However, adirectexperimental validation
isunderway. Themeasurementofspecificurinarymercapturic
acidsoffersthepotentialofsensitivedetectionofexposure, par-
ticularly foralkylating agents forwhichthisis amajorpathway
ofexcretion, such asacrylamide.
Endogenousnitrosationcanarisefromendogenous sourcesof
nitrosating agents such as macrophage-mediated synthesis of
nitric oxideorexogenous sourcessuchasnitrogenoxides(NO,)
from cigarette smoke or urban pollution. Measurements of
nitrotyrosineand itsmetabolitesofferapossibility toquantitate
this factorandarebeingused, particularly in studies involving
urbanpollution.
Eachofthethreeapproachesdescribed inthispaperhavethe
potential to convey information aboutvarious aspects ofhuman
exposure to alkylating carcinogens. It is clear, however, that a
combination ofthese approaches is more powerful than when
they areapplied individually. Forexample, DNAadducts aris-
ingfrompreformedtobacco-specific nitrosamines canbereadily
determinedusingurinaryadducts, butitwillbeinteresting, inad-
dition, to assess the role ofendogenous nitrosation oftobacco
alkaloids, using 3-nitrotyrosine, as this may be a major con-
tributing pathway.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers inHumanCancer: Applications in Molecular Epidem-
iology and RiskAssessmentthatwasheld inKailua-Kona, Hawaii, 26October-l
November 1991.
The technical assistance ofLiliane Garren and Isabelle Brouet is gratefully
acknowledged. Partial funding support from theU.S. National CancerInstitute
is gratefully acknowledged (CA48473).
REFERENCES
1. Marx, J. Zeroing inon individual cancer risk. Science253: 612-616 (1991).
2. Shields, P. G., andHarris, C. C. Molecularepidemiologyandthegenetics
ofenvironmental cancer. J. Am. Med. Assoc. 266: 681-687 (1991).
3. Groopman, J. D., Sabbioni, G., and Wild, C. P. Molecular dosimetry of
humanaflatoxin exposures. In: Molecular Dosimetry and Human Cancer
(J. D. Groopnan andP. L. Skipper, Eds.), CRCPress, BocaRaton, FL, 1991,
pp. 303-324.
4. Phillips, D. H. DNA-adduct analysis by 32P-postlabeling in the study of
human exposure to carcinogens. In: Molecular Dosimetry and Human
Cancer (J. D. Groopmanand P. L. Skipper, Eds.), CRC Press, BocaRaton,
FL, 1991, pp. 151-170.
5. Hecht, S. S., Haley, N. J., andHoffman, D. Monitoringexposuretotobac-
coproductsby measurementofnicotinemetabolitesandderivedcarcinogens.
In: Molecular Dosimetry and Human Cancer (J. D. Groopman and P. L.
Skipper, Eds.), CRC Press, Boca Raton, FL, 1991, pp. 325-361.
6. Craddock, V. M.,andMagee, P. N. Effectofadministrationofthecarcinogen
dimethylnitrosamine onurinary 7-methylguanine. Biochem. J. 104: 435-440
(1967).
7. Gombar, C. T., Zubroff, J., Strahan, G. D., andMagee, P. N. Measurement
of7-methylguanine as anestimate ofdimethylnitrosamine formed following
administrationofaminopyrineandnitritetorats. CancerRes. 43: 5077-5080
(1983).
8. Bennett, R. A., Essigmann, J. M., and Wogan, G. N. Excretion of an
aflatoxin-guanineadductintheurineofaflatoxinBi treatedrats. CancerRes.
41: 650-654 (1981).
9. Karran, P., andLindahl, T. Cellulardefencemechanismagainstalkylating
agents. Cancer Surv. 4: 585-599 (1985).
10. Chasseaud, L. F. The roleofglutathioneand glutathione S-transferases in
themetabolismofchemical carcinogens andotherelectrophilic agents. Adv.
Cancer Res. 29: 175-274(1979).
11. Henderson, P. T., van Door, R., Leijdekkers, C.-M., and Bos, R. P. Ex-
cretionofthioethers in urineafterexposure toelectrophilic chemicals. In:
Monitoring Human Exposure to Carcinogenic and Mutagenic Agents (A.
Berlin, M. Draper, K. Hemminki, and H. Vainio, Eds.), IARC Scientific
Publication No. 59, International Agency for Research on Cancer, Lyon,
1984, pp. 173-187.
12. Hemminki, K. Dimethylnitrosamine adductsexcreted inraturine. Chem.-
Biol. Interact. 39: 139-148 (1982).
13. Suzuki, E., Osabe, M., Okada, M., Ishizaka, T., and Suzuki, T. Urinary
metabolitesofN-nitrosobutylamineandN-nitrobutylamineintherat: identi-
ficationofN-acetyl-S-alkyl-L-cysteines. Jpn. J. Cancer Res. 78: 382-385
(1987).
14. Aringer, L., and Lidums, V. Influenceofdietandother factors on urinary
levelsofthioethers. Int. Arch. Occup. Environ. Health61: 123-130(1988).
15. Jakubowski, M., Linhart, I., Pielas, G., and Kopecky, J. 2-Cyanoethyl-
mercapturic acid (CEMA) inthe urine as apossible indicatorofexposure
toacrylonitrile. Br. J. Ind. Med. 44: 834-840 (1987).URINARYMARKERS FORALKYLATINGAGENSANDPRECURSORS 37
16. Stommel, P.,Muller, G.,Stucker,W.,Veroyen, C.,Schobel,S.,andNorpoth,
K. DeterminationofS-phenylmercapturic acidintheurine: animprovement
inthebiological monitoringofbenzeneexposure. Carcinogenesis 10: 279-282
(1989).
17. Gerin, M., Tardif, R., and Brodeur, J. Determination ofspecific urinary
thioethers derived from acrylonitrile andethylene oxide. In: Methods for
Detecting DNA Damaging Agents in Humans: Applications in Cancer
Epidemiology and Prevention (H. Bartsch, K. Hemminki, and I. K. O'Neill,
Eds.), IARC Scientific Publication No. 89,International AgencyforResearch
on Cancer, Lyon, 1988, pp. 275-278.
18. Toyo'oka, T., Suzuki, T., Saito, Y., andTakahashi, A. Electrochemical detec-
tionofmercapturic acidderivatives after separationby high-performance liq-
uid chromatography. J. Chromatogr. 475: 391-399 (1989).
19. Norstrom, A., Andersson, B., andLevin, J. 0. Aprocedurefortheanalysis
ofS-benzyl-N-acetylcysteine and S-(o-methylbenzyl)-N-acetylcysteine in
human urine. Xenobiotica 16: 525-529 (1986).
20. Ohshima, H., andBartsch, H. Quantitativeestimationofendogenousnitrosa-
tion inhumansby monitoringN-nitrosoprolineexcreted inurine. CancerRes.
41: 3658-3662 (1981).
21. Bartsch, H., Ohshima, H., Pignatelli, B., and Calmels, S. Humanexposure
to endogenous N-nitroso compounds: quantitative estimates in subjects at
high risk forcanceroftheoral cavity, esophagus, stomachandurinaryblad-
der. Cancer Surv. 8: 335-362 (1989).
22. Iqbal, Z. H., Dahl, K., andEpstein, S. S. Roleofnitrogenoxideinthebiosyn-
thesis ofnitrosamines in mice. Science 208: 1475-1477 (1980).
23. Mirvish, S. S., Sams, J. P., andIssenberg, P. Thenitrosatingagentinmice
exposed to nitrogen dioxide: improved extraction method and localization
in the skin. Cancer Res. 43: 2550-2554 (1983).
24. Calmels, S., Ohshima, H., Vincent, P., Gounot, A. M., and Bartsch, H.
Screening ofmicroorganisms for nitrosation catalysis at pH7 and kinetic
studies on nitrosamine formation fromsecondary amines byE. coli strains.
Carcinogenesis 6: 911-915 (1985).
25. Marletta, M. A. Mammalian synthesis ofnitrite, nitrate, nitric oxide, and
N-nitrosating agents. Chem. Res. Toxicol. 1: 249-257 (1988).
26. Margison, G. P., andO'Connor, P. J. Nucleicacidmodificationby N-nitroso
compounds. In: Chemical Carcinogens andDNA(P. L. Grover, Ed.), CRC
Press, Boca Raton, FL, 1979, pp. 111-159.
27. Prevost,V.,Shuker,D. E.G.,Bartsch, H.,Pastorelli,R.,Stillwell, W. G.,Tru-
del, L.J.,andTannenbaum, S. R. Thedeterminationofurinary 3-methylade-
ninebyimmonoaffinitychromatography-monoclonalantibody-basedELISA:
useinhumanbiomonitoring studies. Carcinogenesis 11: 1747-1751 (1990).
28. Eberle, G., Glusenkamp, K. H., Drosdziok, W., and Rajewsky, M. F.,
Monoclonal antibodies forthespecificdetectionof3-alkyladenines innucleic
acids and body fluids. Carcinogenesis 11: 1753-1759 (1990).
30. LIn, D. X., Friesen, M., Malaveille, C., Shuker, D. E. G.,andBartsch, H.
Urinary excretionofS-benzylmercapturic acidasanindicatorofN-nitroso-
N-methylbenzylamine exposure. Cancer Lett. 57: 193-198 (1991).
31. Ohshima, H., Friesen, M., Brouet, I., andBartsch, H. Nitrotyrosine as a
newmarkerforendogenousnitrosationandnitrationofproteins. FoodChem.
Toxicol. 28: 647-652 (1990).
32. Lawley, P. D., and Shah, S. A. Methylationofribonucleic acid by the car-
cinogensdimethylsulphate, N-methyl-N-nitrosourea andN-methyl-N '-nitro-
N-nitrosoguanidine. Biochem. J. 128: 117-132 (1972).
33. Pegg, A. E. Alkylation oftransferRNAby N-methyl-N-nitrosourea and N-
ethyl-N-nitrosourea. Chem.-Biol. Interact. 6: 393-406 (1973).
34. O'Connor, P. J., Capps, M. J., Craig, A. W., Lawley, P. D., andShah, S. A.
Differences inthepatterns ofmethylation in ratliver ribosomal ribonucleic
acid after reaction in vivo with methyl methanesulphonate and NN-di-
methylnitrosamine. Biochem. J. 129: 519-528 (1972).
35. McElhone, M. J., O'Connor, P. J., andCraig, A. W. Thestabilityofratliver
ribonucleic acid in vivo after methylation with methanesulphonate or di-
methylnitrosamine. Biochem. J. 125: 821-827 (1971).
36. Margison, G. P., Margison, J. M., and Montesano, R. Persistence of
methylated bases in ribonucleic acid of Syrian golden hamster after ad-
ministration ofdimethylnitrosamine. Biochem. J. 177: 967-973 (1979).
37. DenEngelse, L., Menkveld, G. J., DeBrij, R.-J., andTates, A. D. Forma-
tionand stability ofalkylatedpyrimidinesandpurines (including imidazole
ring-opened7-alkylguanine)andalkylphosphotriesters inliverDNAofadult
ratstreated withethylnitrosoureaanddimethylnitrosamine. Carcinogenesis
7: 393-403 (1986).